Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up

Non-selective beta-blockers are the mainstay of medical therapy for portal hypertension in liver cirrhosis. Inhibitors of phosphodiesterase-5 (PDE-5-inhibitors) reduce portal pressure in the acute setting by > 10% which may suggest a long-term beneficial effect. Currently, there is no available d...

Descripción completa

Detalles Bibliográficos
Autores principales: Deibert, Peter, Lazaro, Adhara, Stankovic, Zoran, Schaffner, Denise, Rössle, Martin, Kreisel, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776405/
https://www.ncbi.nlm.nih.gov/pubmed/29391766
http://dx.doi.org/10.3748/wjg.v24.i3.438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776405/
https://www.ncbi.nlm.nih.gov/pubmed/29391766
http://dx.doi.org/10.3748/wjg.v24.i3.438

Ejemplares similares